Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)

NCT05797740 is registered in ClinicalTrials.gov with Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany as lead sponsor.

NCT NCT05797740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)
Lead sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase
Observational
Overall status
Active, not recruiting
Start date
August 3, 2023
Completion date
January 31, 2029
Enrollment
366 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis